`

Treadwell Therapeutics, Inc

Biotechnology Research

revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$91.0M
size-icon Size
11 - 50

Frequently Asked Questions About Treadwell Therapeutics, Inc

What does Treadwell therapeutics, inc do?+

Treadwell Therapeutics is a clinical-stage biotechnology company developing novel therapeutics for highly aggressive cancers by targeting critical tumor-specific vulnerabilities including aneuploidy and immunogenicity. The Companys robust, internally developed pipeline includes novel small molecule drugs in single agent and combination studies. Lead candidate, CFI-400945, is a PLK4 inhibitor in multiple Phase 1 and Phase 2 trials including for TNBC, prostate cancer and AML. Additional product candidates include CFI-402257, a clinical stage TTK inhibitor, as well as CFI-402411, a preclinical HPK1 inhibitor (IND filing 1H20), which is positioned to be the first clinical stage small molecule modulator of a unique node of...

What is Treadwell therapeutics, inc's industry? +

Treadwell therapeutics, inc operates in the Biotechnology research industry.

What is Treadwell therapeutics, inc's revenue? +

Treadwell therapeutics, inc's revenue is 11m - 100m

What is Treadwell therapeutics, inc's company size? +

Treadwell therapeutics, inc has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.